( NASDAQ-NMS:AMRI )

News from AMRI A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

09 May, 2017, 07:30 ET AMRI Announces First Quarter 2017 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2017 and provided an update to its outlook...


02 May, 2017, 08:00 ET AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services

AMRI (NASDAQ: AMRI) today announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences...


26 Apr, 2017, 08:00 ET SSCI Receives a 2017 Biotechnology Award for Global Research and Manufacturing

WEST LAFAYETTE, Ind., April 26, 2017 /PRNewswire/ -- SSCI, a division of Albany Molecular Research Inc. (AMRI), has been recognized by Global...


25 Apr, 2017, 08:00 ET AMRI Schedules First Quarter 2017 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2017 financial results before the opening of the market on Tuesday, May 9, 2017....


22 Mar, 2017, 08:00 ET AMRI Receives CMO Leadership Awards for Excellence

AMRI (NASDAQ: AMRI), a global contract research, development and manufacturing organization that has been working with the life sciences...


03 Mar, 2017, 08:00 ET AMRI to Present at Barclays Global Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the...


21 Feb, 2017, 08:05 ET AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products

AMRI (NASDAQ: AMRI) today announced that it has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare, Inc....


21 Feb, 2017, 07:28 ET AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook

AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2016 and provided an...


15 Feb, 2017, 08:00 ET AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2016 financial results before the opening of the market on Tuesday,...


07 Feb, 2017, 08:00 ET AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery

AMRI (NASDAQ: AMRI), a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered...


13 Dec, 2016, 08:00 ET AMRI CEO to Present at 35th Annual J.P. Morgan Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


29 Nov, 2016, 07:45 ET AMRI Announces API Supply Agreement with Shire

AMRI (NASDAQ: AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing,...


14 Nov, 2016, 07:45 ET AMRI to Present Two Posters at AAPS 2016

AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be presenting two posters at the 2016 AAPS Annual...


08 Nov, 2016, 07:30 ET AMRI Announces Third Quarter 2016 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2016 and reiterated its outlook for...


20 Oct, 2016, 08:00 ET AMRI Schedules Third Quarter 2016 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue third quarter 2016 financial results before the opening of the market on Tuesday, November 8,...


03 Oct, 2016, 09:27 ET AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona

 AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be showcasing its comprehensive portfolio...


30 Aug, 2016, 08:00 ET AMRI CEO to Present at Morgan Stanley Global Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


24 Aug, 2016, 08:00 ET AMRI CEO to Present at Baird 2016 Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


23 Aug, 2016, 16:05 ET AMRI Licenses CRISPR-Cas9 Gene Editing Technology

 AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and...


04 Aug, 2016, 07:30 ET AMRI Announces Second Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2016 and provided an update to its...


15 Jul, 2016, 08:00 ET AMRI to Announce Second Quarter 2016 Results

AMRI (NASDAQ: AMRI) today announced it will issue second quarter 2016 financial results before the opening of the market on Thursday, August 4,...


11 Jul, 2016, 07:25 ET AMRI Completes Acquisition of Euticals

 AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as "Euticals", a...


22 Jun, 2016, 08:00 ET Teewinot Life Sciences Corporation Licenses Biosynthetic Technology to AMRI for the Production and Sale of the First Commercially Available CBCA Analytical Standard

 Teewinot Life Sciences Corporation (Teewinot) and Albany Molecular Research, Inc. (NASDAQ: AMRI) today announced that AMRI has licensed...


14 Jun, 2016, 08:05 ET AMRI Selected as a Dedicated Chemical Biology Consortium Center to Expand Drug Development

 AMRI (NASDAQ: AMRI) today announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology...


23 May, 2016, 08:00 ET AMRI CEO to Present at Jefferies 2016 Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...